JP7852839B2 - 菌体可溶化画分を用いた、ヘリコバクター・スイス抗体の検出法 - Google Patents

菌体可溶化画分を用いた、ヘリコバクター・スイス抗体の検出法

Info

Publication number
JP7852839B2
JP7852839B2 JP2023576955A JP2023576955A JP7852839B2 JP 7852839 B2 JP7852839 B2 JP 7852839B2 JP 2023576955 A JP2023576955 A JP 2023576955A JP 2023576955 A JP2023576955 A JP 2023576955A JP 7852839 B2 JP7852839 B2 JP 7852839B2
Authority
JP
Japan
Prior art keywords
swiss
pylori
solubilized fraction
sample
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023576955A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023145787A1 (https=
JPWO2023145787A5 (https=
Inventor
英則 松井
絵美子 林原
仁人 鈴木
崇道 高橋
明 石井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JAPAN INSTITUTE FOR HEALTH SECURITY
Denka Co Ltd
Kitasato Institute
Original Assignee
JAPAN INSTITUTE FOR HEALTH SECURITY
Denka Co Ltd
Kitasato Institute
Denki Kagaku Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JAPAN INSTITUTE FOR HEALTH SECURITY, Denka Co Ltd, Kitasato Institute, Denki Kagaku Kogyo KK filed Critical JAPAN INSTITUTE FOR HEALTH SECURITY
Publication of JPWO2023145787A1 publication Critical patent/JPWO2023145787A1/ja
Publication of JPWO2023145787A5 publication Critical patent/JPWO2023145787A5/ja
Application granted granted Critical
Publication of JP7852839B2 publication Critical patent/JP7852839B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56922Campylobacter
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
JP2023576955A 2022-01-25 2023-01-25 菌体可溶化画分を用いた、ヘリコバクター・スイス抗体の検出法 Active JP7852839B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022009273 2022-01-25
JP2022009273 2022-01-25
PCT/JP2023/002328 WO2023145787A1 (ja) 2022-01-25 2023-01-25 菌体可溶化画分を用いた、ヘリコバクター・スイス抗体の検出法

Publications (3)

Publication Number Publication Date
JPWO2023145787A1 JPWO2023145787A1 (https=) 2023-08-03
JPWO2023145787A5 JPWO2023145787A5 (https=) 2024-10-08
JP7852839B2 true JP7852839B2 (ja) 2026-04-28

Family

ID=87471557

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023576955A Active JP7852839B2 (ja) 2022-01-25 2023-01-25 菌体可溶化画分を用いた、ヘリコバクター・スイス抗体の検出法

Country Status (5)

Country Link
US (1) US20250155434A1 (https=)
EP (1) EP4465043A4 (https=)
JP (1) JP7852839B2 (https=)
CN (1) CN118591728A (https=)
WO (1) WO2023145787A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006284567A (ja) 2005-03-08 2006-10-19 Pharma Foods International Co Ltd ヘリコバクター・ピロリ感染の診断方法及び診断キット
US20090285856A1 (en) 2006-11-14 2009-11-19 Universiteit Gent Helicobacter species and cultivation thereof
WO2019225639A1 (ja) 2018-05-23 2019-11-28 学校法人北里研究所 ヘリコバクター・スイス感染の診断法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139840B4 (de) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
JP3341629B2 (ja) * 1997-05-06 2002-11-05 富士レビオ株式会社 ヘリコバクター・ピロリ除菌治療の診断用試薬
JP2016010331A (ja) 2014-06-27 2016-01-21 学校法人北里研究所 ヘリコバクター・スイス特異的配列、及び当該配列及び当該配列にコードされているタンパク質を標的とした診断方法
JP6965948B2 (ja) 2015-11-24 2021-11-10 株式会社三洋物産 遊技機

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006284567A (ja) 2005-03-08 2006-10-19 Pharma Foods International Co Ltd ヘリコバクター・ピロリ感染の診断方法及び診断キット
US20090285856A1 (en) 2006-11-14 2009-11-19 Universiteit Gent Helicobacter species and cultivation thereof
WO2019225639A1 (ja) 2018-05-23 2019-11-28 学校法人北里研究所 ヘリコバクター・スイス感染の診断法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
RIMBARA,Emiko et al.,Isolation and characterization of Helicobacter suis from human stomach,PNAS,2021年,Vol.118, No.13,e2026337118,doi.org/10.1073/pnas.2026337118
松井 英則 ほか,ヘリコバクター・スイス感染の迅速診断法の開発,日本ヘリコバクター学会誌,2020年,Vol.21, No.2,pp.121-127

Also Published As

Publication number Publication date
US20250155434A1 (en) 2025-05-15
CN118591728A (zh) 2024-09-03
JPWO2023145787A1 (https=) 2023-08-03
WO2023145787A1 (ja) 2023-08-03
EP4465043A4 (en) 2025-04-02
EP4465043A1 (en) 2024-11-20

Similar Documents

Publication Publication Date Title
JP7105970B1 (ja) SARS-CoV-2の免疫測定方法及び免疫測定キット
CN112679605B (zh) 针对新型冠状病毒核衣壳蛋白的抗体或其抗原结合片段及其应用
JP7216948B1 (ja) SARS-CoV-2の免疫測定方法及び免疫測定キット、並びにモノクローナル抗体又はその抗体断片
US20150192583A1 (en) Hbv immunocomplexes for response prediction and therapy monitoring of chronic hbv patients
CN103380379B (zh) 尿路感染的诊断方法
JP6867529B1 (ja) ヘリコバクター・ピロリ検出用抗体
US20220120737A1 (en) Method for detecting sars-cov-2-specific serum human immunoglobulins
JP6048923B2 (ja) B型慢性肝炎の検出方法および検出キット
US20230333097A1 (en) KIT FOR DETECTING ANTI-VINCULIN-IMMUNOGLOBULIN G (IgG) ANTIBODY
US20240044895A1 (en) Identification of sars-cov-2 epitopes discriminating covid-19 infection from control and methods of use
JP7852839B2 (ja) 菌体可溶化画分を用いた、ヘリコバクター・スイス抗体の検出法
JP7854592B2 (ja) 菌体外膜画分を用いた、ヘリコバクター・スイス抗体の検出法
JP7854593B2 (ja) 全菌体を用いた、ヘリコバクター・スイス抗体の検出法
KR20210144562A (ko) Covid-19의 급성 호흡기 증후군 바이오마커 검출용 조성물 및 키트
EP4467979A1 (en) Method for detecting helicobacter suis antibody using bacterial outer membrane fraction
US20250110123A1 (en) Method for detecting helicobacter suis antibody using whole cell
JP7489228B2 (ja) SARS-CoV-2由来ヌクレオカプシド断片および該断片を用いて抗SARS-CoV-2抗体を検出する方法およびキット
WO2004048976A1 (ja) 黄色ブドウ球菌の検査方法
WO2020158811A1 (ja) ヘリコバクター・ピロリ菌株の同定方法、および同定用キット
EP4033247A1 (en) Multi-species immunoassays for detecting antibodies anti-sars-cov-2 using protein a for detection of captured antibodies
JP2023547188A (ja) 住血吸虫感染症の検出のためのタンパク質
WO2021240425A1 (en) A method for rapid detection of antibodies against sars-cov-2 using recombinant nucleospike fusion protein
HK40104164A (zh) 用於检测血吸虫感染的蛋白质
CN114544958A (zh) 一种检测SARS-CoV-2抗原的试剂盒、方法以及用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240805

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240805

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250708

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250904

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20251030

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20251030

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260114

TRDD Decision of grant or rejection written
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20260304

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260310

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20260312

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20260304

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260403